292 related articles for article (PubMed ID: 29351706)
1. MicroRNAs and Target Genes in Pituitary Adenomas.
Feng Y; Mao ZG; Wang X; Du Q; Jian M; Zhu D; Xiao Z; Wang HJ; Zhu YH
Horm Metab Res; 2018 Mar; 50(3):179-192. PubMed ID: 29351706
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in the human pituitary.
Sivapragasam M; Rotondo F; Lloyd RV; Scheithauer BW; Cusimano M; Syro LV; Kovacs K
Endocr Pathol; 2011 Sep; 22(3):134-43. PubMed ID: 21647843
[TBL] [Abstract][Full Text] [Related]
3. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
4. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
5. The Involvement of miRNAs in Pituitary Adenomas Pathogenesis and the Clinical Implications.
Xu D; Wang L
Eur Neurol; 2022; 85(3):171-176. PubMed ID: 35034033
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: Suggested role in pituitary adenoma pathogenesis.
Gadelha MR; Kasuki L; Dénes J; Trivellin G; Korbonits M
J Endocrinol Invest; 2013 Nov; 36(10):889-95. PubMed ID: 24317305
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.
Wei Z; Zhou C; Liu M; Yao Y; Sun J; Xiao J; Ma W; Zhu H; Wang R
Pituitary; 2015 Oct; 18(5):710-21. PubMed ID: 25862551
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior.
Vicchio TM; Aliquò F; Ruggeri RM; Ragonese M; Giuffrida G; Cotta OR; Spagnolo F; Torre ML; Alibrandi A; Asmundo A; Angileri FF; Esposito F; Polito F; Oteri R; Aguennouz MH; Cannavò S; Ferraù F
J Endocrinol Invest; 2020 Jul; 43(7):947-958. PubMed ID: 31939196
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
10. Mir-23b and miR-130b expression is downregulated in pituitary adenomas.
Leone V; Langella C; D'Angelo D; Mussnich P; Wierinckx A; Terracciano L; Raverot G; Lachuer J; Rotondi S; Jaffrain-Rea ML; Trouillas J; Fusco A
Mol Cell Endocrinol; 2014 Jun; 390(1-2):1-7. PubMed ID: 24681352
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Notch3 receptor in non-functioning pituitary tumours.
Miao Z; Miao Y; Lin Y; Lu X
J Clin Neurosci; 2012 Jan; 19(1):107-10. PubMed ID: 22153798
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
[TBL] [Abstract][Full Text] [Related]
14. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
15. Strategies to use microRNAs as therapeutic targets.
Gentilin E; Degli Uberti E; Zatelli MC
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):629-639. PubMed ID: 27923456
[TBL] [Abstract][Full Text] [Related]
16. [The role of miRNAs in the pathogenesis of pituitary adenomas].
Németh K; Darvasi O; Szücs N; Czirják S; Butz H
Orv Hetil; 2018 Feb; 159(7):252-259. PubMed ID: 29429349
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
18. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.
Tofrizal A; Fujiwara K; Azuma M; Kikuchi M; Jindatip D; Yashiro T; Yamada S
Med Mol Morphol; 2017 Sep; 50(3):145-154. PubMed ID: 28353090
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors.
Müssnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Wierinckx A; Trouillas J; Fusco A; D'Angelo D
Cell Cycle; 2015; 14(16):2590-7. PubMed ID: 26125663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
